AB secures global approvals for HiRes Optima system


Advanced Bionics (AB), a subsidiary of Sonova. has received approvals from the FDA, Health Canada and Germany's TÜV for the global distribution of its HiRes Optima sound processing system to aid hearing loss. The system delivers optimised battery life with the same performance as AB's patented HiRes Fidelity 120 processing. According to AB, cochlear implant recipients using this technology have an average improvement of 55 per cent in battery life.

AB built HiRes Optima processing system on the HiRes Fidelity 120 platform to benefit from its built-in performance capabilities. HiRes Optima provides the same detailed sound with an improved battery life. Benefitting from the HiRes Fidelity 120 platform, HiRes Optima also delivers AB's proprietary current steering technology, giving AB cochlear implant recipients the opportunity to hear more pitches. Recipients using research software have demonstrated the ability to perceive up to 450 pitches.

The system will be available for use with AB's next-generation sound processor as well as Neptune and Harmony processors. However, the HiRes Optima sound processing system has not been approved for paediatric patients in the US.

This article is tagged to:
Sector: Medical Devices
Geography: Germany, Canada, United States